PHIO - Phio Pharmaceuticals Corp
1.33
-0.020 -1.504%
Share volume: 195,582
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$1.35
-0.02
-0.01%
Summary score
13%
Profitability
8%
Dept financing
6%
Liquidity
50%
Performance
10%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.43%
Return on assets
-21.94%
Return on sales
0%
Return on invested capital
135.28%
Total debt ratio
17.25%
Debt ratio change over timeo
-0.87%
Current Ratio
6.29%
Quick Ratio
0%
Cash Position Ratio
5.9%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-25.51%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
19.04%
Debt ratio change over timeo
-0.86%
Current Ratio
5.32%
Quick Ratio
0%
Cash Position Ratio
4.92%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-31.43%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
18.23%
Debt ratio change over time
-0.87%
Current Ratio
5.48%
Quick Ratio
0%
Cash Position Ratio
5.18%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.94%
Return on assets
-116.06%
Return on sales
0%
Return on invested capital
-29.05%
Total debt ratio
-87.49%
Debt ratio change over time
-0.87%
Current Ratio
3.45%
Quick Ratio
0%
Cash Position Ratio
3.17%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PHIO | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -9.43% | 18.83% | 17.34% | 0% |
| Return on assets | -21.94% | 4.14% | 8.21% | 0% |
| Return on sales | 0% | 27.93% | 41.18% | 0% |
| Return on invested capital | 135.28% | 9.79% | -219.55% | 0% |
| Profitability | 25% | 56% | 73% | 0% |
| Total debt ratio | 17.25% | 82.52% | 55.88% | 0% |
| Debt ratio change over time | -0.87% | -13.08% | -0.73% | 0% |
| Dept financing | 5% | 25% | 17% | 25% |
| Current Ratio | 5.32% | 1.13% | 0% | 0% |
| Quick Ratio | 0% | 0.87% | 0% | 0% |
| Cash Position Ratio | 4.92% | 0.12% | 0% | 0% |
| Liquididy | 50% | 31% | 28% | 0% |
| Short-term ratios | PHIO | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 13.31% | 0% | 0% |
| Return on assets | -25.51% | 4.46% | 0% | 0% |
| Return on sales | 0% | 29.96% | 0% | 0% |
| Return on invested capital | 0% | 10.68% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 19.04% | 81.12% | 0% | 0% |
| Debt ratio change over time | -0.86% | -58.72% | 0% | 0% |
| Dept financing | 6% | 25% | 25% | 0% |
| Current Ratio | 5.32% | 1.13% | 0% | 0% |
| Quick Ratio | 0% | 0.87% | 0% | 0% |
| Cash Position Ratio | 4.92% | 0.12% | 0% | 0% |
| Liquididy | 50% | 31% | 0% | 0% |